TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Otsuka Pharma Scandinavia AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
224,916
|
214,979
|
207,282 |
Financial expenses |
2
|
25
|
149 |
Earnings before taxes |
6,120
|
7,867
|
6,709 |
EBITDA |
5,960
|
8,114
|
7,188 |
Total assets |
88,613
|
81,075
|
75,103 |
Current assets |
88,153
|
80,737
|
74,703 |
Current liabilities |
55,691
|
46,848
|
39,216 |
Equity capital |
32,922
|
34,227
|
35,887 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
38
|
35
|
36 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
37.2%
|
42.2%
|
47.8% |
Turnover per employee |
5,919
|
6,142
|
5,758 |
Profit as a percentage of turnover |
2.7%
|
3.7%
|
3.2% |
Return on assets (ROA) |
6.9%
|
9.7%
|
9.1% |
Current ratio |
158.3%
|
172.3%
|
190.5% |
Return on equity (ROE) |
18.6%
|
23.0%
|
18.7% |
Change turnover |
8,829
|
24,487
|
-9,958 |
Change turnover % |
4%
|
13%
|
-5% |
Chg. No. of employees |
3
|
-1
|
-6 |
Chg. No. of employees % |
9%
|
-3%
|
-14% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.